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Skill development in the pharmaceutical sector in India
George Patani
Email: gpatani@gmail.com
In the recent past, the Indian pharmaceutical
industry has been changing rapidly, as a result of
globalization and the large dependence on the Indian
industry for the supply of quality pharmaceutical
products. To ensure its continued success, Indian
pharmaceutical corporations will need to introduce
quality specialty products, for which they will
require more skilled and qualified man power. The
emphasis of the current Indian government on the
development of skills across all industry sectors
is well thought and is a logical extension of its
“Make in India” program. We are all well aware that
there exists a gap between academia and industry
and the Human Resource Department of every
industrial organization, including those in the
pharmaceutical industry, desires graduates who are
more knowledgeable about the needs of the industry
and trained to serve these needs. Academia in India,
as compared to the developed nations, lags behind
the industry with regards to current manufacturing
trends, innovation and research. We acknowledge
that there exists a need to bridge this gap and
numerous efforts have been made to reduce the
differences between reality and that what is desired.
In view of the multi-dimensional skills involved in
the operation of a pharmaceutical company, a multifaceted approach must be used to ensure skill up
gradation of personnel involved in all functions of
putting a product into the market.
Until 2015, eleven NIPERs were approved and
in 2016 the Government of India has approved
three more NIPERs in Chhattisgarh, Maharashtra
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and Rajasthan. Considering the large number of
government and private pharmacy colleges in
India, one of the approaches of bridging the gap,
between academia and industry is by ensuring that
the Bachelor of Pharmacy and Master of Pharmacy
curriculums in these institutions are current and
relevant. The role of the Pharmacy Council of
India in updating the syllabus of the BPharm
program is noteworthy. However, in view of the
long interval between the previous revisions, it may
be a good suggestion to have a core curriculum,
which is uniform across the country and flexibility
may be granted to progressive academic institutions
to offer additional electives that are now required
in the functional working of the pharmaceutical
industry. Some of the developments that have
provided opportunities for the introduction of new
disciplines of study are enumerated here. New
concepts in pharmaceutical production such as
continuous manufacturing processes and process
analytical technologies offer interesting new areas
for specialization. In the area of Quality Assurance
students must be exposed to systems, commonly
used in pharmaceutical quality management, such as
Deviation Management, Change Control Procedures,
OOS etc., early in their careers, to enable them to
adapt quickly once they start their careers in the
industry. Apart from the knowledge of Schedule M,
21 CFR, ICH Q7 and other international regulatory
requirements, students must be trained with
language and interpersonal skills to prepare them to
interact with international regulators and auditors.
While traditional pharmaceutical jurisprudence has
been a subject in the curriculum since long, students
must be sensitized to Trademark and Patent laws,
the Drug Price Control Order 2013 and the Uniform
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Code of Pharmaceutical Marketing Practice, which
is currently a guideline and not enacted as law.
The Indian Pharmacopoeia Commission has been
entrusted with implementing the Pharmacovigilance
Program of India. With its formalisation since 2010,
pharmaceutical companies are required to ensure
compliance with the pharmacovigilance program,
resulting in a need for trained personnel who are
knowledgeable with the best pharmacovigilance
practices.
Further, in the past new drug discovery research
involved the chemical modification of small
molecules, while, current drug discovery programs
primarily involve development of complex large
molecules commonly called biosimilars. Hence, with
the rapid changes in the industry it is desirable that
curriculum up gradation be perceived as a continuous
process that must be done periodically.
The government has also established many large
research institutions like the Council for Scientific
and Industrial Research (CSIR) and Indian
Council for Medical Research (ICMR) to create
a culture of product development based on basic
scientific research. There must be a purposeful
mandate among these institutions to develop
technologies that are of national importance. These
government institutions must be coerced to license
out these technologies to national pharmaceutical
organizations for commercialization. This will
ensure that the products are developed to a level of
market readiness for immediate commercialization.

It may also be noted that these large government
research institutions have also played a role in
providing the pharmaceutical sector technical,
trained scientists, some of whom have established
companies and are today successful entrepreneurs.
This again is another noteworthy initiative that
provides the pharmaceutical sector with skilled
professionals.
Industry associations such as the Indian Drug
Manufacturers’ Association (IDMA) have been
facilitating workshops and training programs
for the industry in collaboration with various
international certification bodies such as UL and
NSF International to upgrade the skill sets of
personnel in the pharmaceutical industry involved
with the Quality Unit. These workshops and
programs bring international experts to India and
allow greater number of personnel to interact with
these experts.
Further, programs have been organized to showcase
the facilities and the capabilities of faculty members
at the various academic institutions encouraging
industry members to utilize these facilities and to
interact more with academia resulting in mutual
benefit. With academia and industry busy with their
own mandates to further expand their operations
and garner more profit, the onus is now on industry
associations to be the catalyst, to coax its industry
members to shoulder greater responsibility and
ensure that the pharmaceutical workforce for the
future is qualified, well-trained and employable.
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